BFLY Stock Analysis: Buy, Sell, or Hold?
BFLY - Butterfly Network, Inc.
$7.76
0.49 (6.67%)
▲
5d:
+37.74%
30d:
+73.1%
90d:
+85.08%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 07, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.7/10
Get Alerted When BFLY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: BFLY is 22.3% above its trading range ($6.34). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: BFLY is 22.3% above its trading range ($6.34). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: BFLY is currently trading at $7.75, which is considered extended relative to its 30-day fair value range of $3.99 to $6.34.
Technical Outlook: Technically, BFLY is in a strong downtrend. Immediate support is located at $4.74, while resistance sits at $8.94. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: BFLY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BFLY is in a strong downtrend. Immediate support is located at $4.74, while resistance sits at $8.94. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: BFLY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.99 -
$6.34
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding BFLY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+22.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.7%)
- NEUTRAL: Near Wall St target ($7.06)
- WARNING: Recommendation downgraded due to 22.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$3.99 -
$6.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.74
Resistance Level
$8.94
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-78.59
Wall Street Target
$7.06
(-2.9%)
Revenue Growth (YoY)
25.0%
Profit Margin
-73.6%
Share & Embed Analysis
Last updated: June 23, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BFLY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Jonathan M Rothberg
SELL
335834 shares
2026-01-08
John N Doherty
SELL
60182 shares
2026-01-07
Jonathan M Rothberg
SELL
452729 shares
2026-01-07
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
Advanced BFLY Option Strategies
Professional options setups generated by AI based on today's BFLY price and gamma walls.
